Viewing Study NCT00227461


Ignite Creation Date: 2025-12-24 @ 1:03 PM
Ignite Modification Date: 2025-12-28 @ 5:33 PM
Study NCT ID: NCT00227461
Status: UNKNOWN
Last Update Posted: 2021-02-17
First Post: 2005-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
Sponsor: Kessler Foundation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-09
Start Date Type: ACTUAL
Primary Completion Date: 2021-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12
Completion Date Type: ESTIMATED
First Submit Date: 2005-09-26
First Submit QC Date: None
Study First Post Date: 2005-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-16
Last Update Post Date: 2021-02-17
Last Update Post Date Type: ACTUAL